SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Merck Reports Favorable Overall Survival Trend for Keytruda Monotherapy

Merck said a favorable overall survival trend was observed for Keytruda monotherapy versus platinum doublet chemotherapy.

MRK

Related stories